Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stuart Marshall

Orthopaedic Surgery Draper, UT Medical Doctor

NPI 1447204821 CMS profile 1172748

96 E Kimballs Ln Ste 207, Draper, UT 84020

Open in the dashboard

General payments

$62,845

112 records reported · program years 2019–2025

Research payments

$36,684

Paid to them · 21 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stuart Marshall of Draper, UT is reported in the CMS Open Payments database as having received $62,845 across 112 general payments and $36,684 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,208 14
2024 General $18,231 26
2023 General $259 8
2022 General $1,037 10
2021 General $1,629 21
2020 General $23,731 11
2020 Research $8,046 5
2019 General $15,751 22
2019 Research $28,638 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stuart Marshall
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Stuart Marshall were reported at $2,208. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Stuart Marshall Orthopaedic Surgery median Middle half National median
2019 $15,751 $644 $140–$2,844 $163
2020 $23,731 $312 $75–$1,860 $114
2021 $1,629 $520 $117–$2,495 $132
2022 $1,037 $598 $128–$2,731 $149
2023 $259 $461 $128–$2,264 $160
2024 $18,231 $497 $134–$2,475 $164
2025 $2,208 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medacta USA, Inc. $62,151 89 payments
  2. Limacorporate S.p.A. $150 2 payments
  3. Stryker Corporation $139 1 payment
  4. DePuy Synthes Sales Inc. $96 4 payments
  5. Globus Medical, Inc. $71 4 payments
  6. Smith+Nephew, Inc. $67 2 payments
  7. Anika Therapeutics, Inc. $54 3 payments
  8. Vericel Corporation $48 2 payments
  9. Ferring Pharmaceuticals Inc. $28 2 payments
  10. Mayne Pharma Inc. $20 1 payment
  11. Other $22 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $32,207 34 payments
  2. Consulting Fee $26,800 7 payments
  3. Food and Beverage $3,838 71 payments
Products named General payments · program years 2019–2025
  1. GMK SPHERE $30,907 19 payments
  2. Mecta-C Cervical Cages $14,631 17 payments
  3. PRIMARY SHOULDER $5,068 3 payments
  4. GMK Sphere Revision System $3,132 3 payments
  5. GMK $2,586 2 payments
  6. AMISTEM $2,408 18 payments
  7. Mecta Orthopedics/Orthopedic Surgery $1,667 7 payments
  8. MECTA Sports Medicine $386 4 payments
  9. Snugfit $363 4 payments
  10. REVERSE SHOULDER $282 5 payments
  11. Other $2,164 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medacta USA, Inc. $36,684 21 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

40

Median for Orthopedic Surgery: 203

Drug cost

$320

Median for Orthopedic Surgery: $1,433

Branded share of claims

55%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 22 $169
Cephalexin Generic 18 $151

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$134,852

Of which drugs: $17,720

Medicare patients

231

Average age 73

Services billed

2,279

125 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Diabetes 29%
Chronic kidney disease 27%
Ischemic heart disease 24%
Depression 23%
Atrial fibrillation 15%
Heart failure 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 45 174 $16,096
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 80 1,062 $817

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record